Identifying factors which maximise the lambing performance of hoggets: a cross sectional study

AIM: To identity perceptions of farmers with respect to advantages of hogget lambing and to identify optimal management strategies for hogget lambing used in New Zealand.

METHODS: A questionnaire was sent to 1,038 sheep farmers in New Zealand who had indicated their hoggets would be lambing in 2002. Information was gathered on the practice of hogget lambing in New Zealand, in particular on the numbers and breeds of hoggets and rams used, selection criteria used for hoggets, use of teasers (vasectomised rams), length of mating period, use of mating crayons, vaccinations, medications and mineral supplements given, level of feed offered, use of pregnancy scanning, management during pregnancy and lambing, number of lambs present at docking, and shearing policies for hoggets. Farmers were also asked to indicate the relative importance of five stated reasons for choosing to have their hoggets mated in 2002.

RESULTS: A total of 629 (60.6%) responses were incorporated in the analysis, and the average percentage of hogget lambing was 60%. Use of vaccinations, length of the mating period, number of rams used, breed of hogget, weight at mating, management during lactation, and shearing policy were associated (p<0.05) with the lambing performance of hoggets, in the multivariate analysis.

CONCLUSIONS: This study indicated that to ensure high lambing percentages (LP) in hoggets in New Zealand, sheep farmers should: vaccinate hoggets against toxoplasmosis and campylobacteriosis; utilise a 40-day mating period; use 2.6–3.5% of rams during mating; incorporate Finn or East Friesian genetics; ensure liveweights at mating are as high as possible; manage single- and multiple-bearing/-rearing hoggets separately during the lambing and lactation periods; and shear hoggets pre-mating.     

IMAGING DIAGNOSIS—IDIOPATHIC HYOID MALFORMATION IN AN 8‐YEAR‐OLD WELSH SECTION D HORSE

An 8‐year‐old gelding was evaluated for intermittent dorsal displacement of the soft palate (DDSP) at exercise. Standing laterolateral radiographs demonstrated an abnormal crossed appearance of the stylohyoid bones. Computed tomography (CT) confirmed abnormal positioning of the left stylohyoid bone and articulations with both the left thyrohyoid and ceratohyoid bones. Surgical treatment consisted of combined left ceratohyoidectomy and thyrohyoidectomy. Postoperatively the patient's presenting complaint resolved completely, with the horse returning to full work. Standing laterolateral radiographs should be obtained prior to laryngeal or hyoid surgery to rule out hyoid anomalies, which could result in surgical failure or subsequent hyoid fracture.     

FeLV-FAIDS-induced immunodeficiency syndrome in cats

Findings are reviewed, relevant to elucidation of the pathogenic, genetic and biochemical properties of a single, genetically heterogeneous isolate of feline leukemia virus (FeLV-FAIDS) shown to induce fatal immunodeficiency disease in nearly 100% of inoculated cats. Hypotheses are suggested which pertain to the mechanism of T-cell killing by this virus, and which extrapolate findings in the FeLV-FAIDS animal model to AIDS induced in humans by human immunodeficiency virus (HIV).     

Relationship between kennel size and stress in greyhounds transported short distances by air

Greyhounds are usually transported by air between Ireland and England in wooden kennels similar in size to greyhound racing starting traps. These kennels have been criticised in the belief that their small size leads to unnecessary stress. The present study compared plasma ACTH, cortisol, lactate and non-esterified fatty acid concentrations in 12 greyhounds transported either in the existing wooden kennels or in wider perspex kennels, which were stowed either in the belly hold or in the main cargo hold of jet freighter aircraft. Increased kennel size did not appear to result in decreased stress responses but there was a significantly greater stress response in the dogs kept in the belly hold of the aircraft. Individual variation between dogs was the most significant feature of the study.     

Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review

The development of postattenuation neurologic signs (PANS) is a poorly understood and potentially devastating complication after surgical attenuation of congenital portosystemic shunts in dogs. Postattenuation neurologic signs include seizures but also more subtle neurologic signs such as depression, behavioral changes, tremors, and twitching. They most commonly occur within 7 days postoperatively and are typically unrelated to hyperammonemia, hypoglycemia, or electrolyte disturbances. This narrative review summarizes the findings of 50 publications from 1988-2020 that report occurrence of PANS. While most published reports included only dogs affected by postattenuation seizures (PAS), others included dogs with any form of PANS. Overall, PANS (including PAS) affected 1.6%-27.3% of dogs, whereas incidence of PAS ranged from 0%-18.2%. The etiology of PANS remains unknown; however, several theories have been proposed. Risk factors include preoperative hepatic encephalopathy, increasing age, and possibly certain breeds and extrahepatic shunt morphology. There is increasing evidence that prophylactic antiepileptic drugs do not prevent PANS. Treatment is centered around controlling neurologic signs with antiepileptic drugs and providing supportive intensive care. The 30-day survival rate in studies that included a minimum of four dogs affected by PANS was 0%-100% (median, 50.0%) and 0%-75.0% (median, 37.5%) for those with PAS. Mortality associated with PANS was typically related to occurrence of generalized seizure activity. Prognostic factors positively associated with short-term survival included having a history of preoperative seizures and development of focal seizures only. If affected dogs survived to discharge, survival for several years was possible, and the majority of neurologic signs manifested as part of the phenomenon of PANS appeared to resolve.     

Purification and partial characterization of a cadmium-binding protein from the liver of rainbow trout (Onchorynchus mykiss).

This study describes the isolation and partial characterization of a low molecular weight (approximately 14 kDa), cadmium-binding protein from rainbow trout (Onchorynchus mykiss) liver. Rainbow trout were injected intraperitoneally with 3.5 mg/kg cadmium chloride (total body dose) twice weekly for 3 wk. Livers were removed and a cadmium-binding protein was isolated. Monoclonal antibodies produced against this protein were used in the affinity purification process. Amino acid analysis showed the protein contained 3.8 mol% cysteine, 3.5 mol% phenylalanine, 2.2 mol% tyrosine and 1.9 mol% histidine. The low cysteine content suggests that it was distinct from metallothionein. The monoclonal antibodies were also used to identify the protein in liver homogenates from both cadmium-exposed and control fish and in the testes of cadmium-exposed mice lacking the gene for both metallothionein-1 and metallothionein-II. The compound identified in this study represents a non-metallothionein cadmium-binding protein that appears to be highly conserved.     

The pharmacokinetics of oclacitinib maleate,a Janus kinase inhibitor,in the dog

The pharmacokinetics of oclacitinib maleate was evaluated in four separate studies. The absolute bioavailability study used a crossover design with 10 dogs. The effect of food on bioavailability was investigated in a crossover study with 18 dogs. The breed effect on pharmacokinetics was assessed in a crossover study in beagles and mongrels dogs. Dose proportionality and multiple dose pharmacokinetics were evaluated in a parallel design study with eight dogs per group. In all four studies, serial blood samples for plasma were collected. Oclacitinib maleate was rapidly and well absorbed following oral administration, with a time to peak plasma concentration of <1 h and an absolute bioavailability of 89%. The prandial state of dogs did not significantly affect the rate or extent of absorption of oclacitinib maleate when dosed orally, as demonstrated by the lack of significant differences in pharmacokinetic parameters between the oral fasted and oral fed treatment groups. The pharmacokinetics of oclacitinib in laboratory populations of beagles and mixed breed dogs also appeared similar. Following oral administration, the exposure of oclacitinib maleate increased dose proportionally from 0.6 to 3.0 mg/kg. Additionally, across the pharmacokinetic studies, there were no apparent differences in oclacitinib pharmacokinetics attributable to sex.